I n early April 2009, human infections caused by pandemic (H1N1) 2009 virus were identifi ed in the United
States (1) and Mexico (2) . The virus then spread rapidly around the world. The People's Republic of China reported its fi rst case of pandemic (H1N1) 2009 on May 10, 2009. As of July 31, a total of 2,090 confi rmed cases had been reported in mainland China. Cases were detected in 25 provinces and municipalities; the largest numbers of cases were found in Guangdong Province, Beijing, and Shanghai. To understand the clinical and epidemiologic characteristics of infected patients, we reviewed medical records of 237 patients with laboratory-confi rmed cases reported in Shanghai during May-July 2009.
The Study
On April 30, 2009, guidelines for surveillance, reporting, diagnosis, and treatment of pandemic (H1N1) 2009 were published by the Ministry of Health of the People's Republic of China (revised May 9) (3). On the basis of these guidelines, the Shanghai Bureau of Health issued a working document for prevention and control of pandemic (H1N1) 2009 in Shanghai.
Briefl y, ill persons with a temperature >37.5°C were asked to visit fever clinics in local general hospitals. A suspected case of pandemic (H1N1) 2009 was defi ned as 1) an infl uenza-like illness (fever >37.5°C with >1 signs or symptoms, including sore throat, cough, runny nose, nasal congestion) in a person who had traveled to a country where >1 case had been confi rmed in the past 7 days or 2) clinical symptoms or signs of infl uenza-like illness in a person epidemiologically linked to a patient with confi rmed or suspected infection identifi ed in the previous 7 days. A confi rmed case was defi ned as laboratory confi rmation of infection by PCR performed on a nasopharyngeal swab specimen at the Shanghai Center for Disease Control and Prevention (Shanghai CDC). All suspected cases were required to be reported to the Shanghai CDC within 24 hours after diagnosis.
Nasopharyngeal swabs obtained from patients with suspected cases were sent to the Shanghai CDC for detection of virus. Virus RNA was extracted and tested for all infl uenza types and specifi c subtypes by using a series of PCRs specifi c for matrix gene sequences of infl uenza A and B viruses. Of the 237 case-patients, 129 (54.4%) were male. Median age of confi rmed case-patients was 24 years (range 2-75 years). Eighty-two percent of case-patients were 10-39 years of age (Figure 2 ).
Patients were from 15 countries; 64.6% of patients were Chinese citizens, 10.1% were Australian citizens, 5.9% were American citizens, and 5.9% were Indonesian citizens. Among the 237 cases, 230 (97.0%) were identifi ed as imported (i.e., confi rmed case in a person with recent travel outside mainland China who had arrived in China during the surveillance period and had illness onset within 7 days after arrival). A total of 115 of these persons were from Australia; 36 from the United States; 18 from Canada; 11 from Indonesia; 10 from Singapore; 8 from the Philippines; 7 from the United Kingdom; 6 from Hong Kong; 4 each from Thailand, Taiwan, and South Korea; 2 each from Argentina and New Zealand; and 1 each from Japan, Mexico, and Italy. Seven The most commonly reported symptoms were fever or history of fever (94.9%), dry cough (51.5%), sore throat (32.9%), runny nose (19.8%), and productive cough (18.1%) (Table) . Only 2 case-patients (a 58-year-old man and a 49-year-old woman) had diarrhea (0.8%). One casepatient was a pregnant (13 weeks) Australian woman (31 years of age) in whom fever (>37.8°C) developed on the second day after she arrived from Sydney. Seventeen patients had underlying medical conditions: asthma (3 patients), obesity (3), allergic rhinitis (2), lymphoma (1), essential hypertension (5), hypothyroidism and hepatitis B (1), and gastric ulcer (2) .
Of the 237 case-patients, 236 (99.6%) received oseltamivir for 5 days; the pregnant woman refused antiviral therapy. Of 236 patients treated, 186 (78.5%) received oseltamivir within 48 hours after illness onset. Median time between onset of symptoms and start of oseltamivir treatment was 2 days (range 1-5 days). All patients had a mild illness. As of July 31, all patients had recovered and were discharged from the hospital. Mean ± SD length of hospital stay was 4.9 ± 1.7 days (range 3-9 days). No severe cases or deaths were reported. No patients were reported to have complications or to require intubation or oxygen.
Conclusions
Our investigation indicates that the outbreak in Shanghai evolved similarly to outbreaks in other regions (4, 5) . The epidemiologic pattern in Shanghai did not differ from that in the Americas and Europe (6) (7) (8) . Pandemic (H1N1) 2009 virus preferentially infects younger age groups. Most patients had mild symptoms and fully recovered within 1 week.
Clinical responses were favorable among these 237 case-patients, including 17 with underlying disease. Patients in this series seemed to benefi t from early antiviral therapy. Early use of oseltamivir may have prevented complications.
Our study indicates that surveillance activities in Shanghai identifi ed a substantial number of cases of pandemic (H1N1) 2009 among travelers early in the outbreak. The early response strategy in Shanghai has been containment; many case-patients were identifi ed quickly after they arrived in China. Our data show that containment may have had a useful role in the initial phase of the outbreak. In Shanghai, patients with infl uenza were hospitalized for isolation purposes. Because the number of infl uenza cases has increased in Shanghai, the quarantine policy has been changed; since August 1, 2009, hospitalization for isolation purposes has not been mandated. Cases of pandemic (H1N1) 2009 in Shanghai during May-July 2009 were identifi ed rapidly and treated with oseltamivir, resulting in mild illness and absence of deaths. As the pandemic evolves, continued investigation is needed to describe its epidemiologic and clinical characteristics.
